Istanbul, Turkey - Early treatment of hemoglobin (Hb) to high- vs standard-target values with epoetin beta (NeoRecormon, Roche) had no significant impact on cardiovascular disease (CVD) events in ...
In a Japanese study, targeting high hemoglobin concentrations of 12.5-13.5 g/dL with erythropoiesis-stimulating agents resulted in longer graft survival. In kidney transplant recipients, targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback